Directed R&D activities in developing analytical methods and formulating both inhalation and oral drug candidates. Developed and managed a Quality program in-house to support Phase 1 GMP activites, which included method qualifications, QC testing, OOS investigations, and training.

Managed the development, validation, and transfer of analytical methods for testing vitamins and dietary supplements in tablets, softgels, capsules and gummy products. Also managed the real time stability program to support product shelf life and workedg closely with USP to ensure product quality regarding raw material and product specifications, testing requirements and test methodologies for dietary supplements.

Directed contract research services in the areas of pre-formulation characterization, formulation development, analytical method development, stability studies, high throughput screenings, investigation of particulates, and lyophilization cycle development.

Managed pre-formulation and formulation development activities for a variety of protein, antibody and peptide products.

Performed stability testing to the determine chemical and physical stability of a protein drug candidate using analytical, biophysical and biochemistry techniques.

Executed pre-formulation, formulation, analytical and biophysical experiments for the advancement of oncology, metabolic and platform extension projects.

Examined the properties and photocycles of light-sensitive proteins with a variety biophysical and analytical instrumentation.Studied the aggregation of native and oxidized alpha-synuclein, a protein related to Parkinson’s disease, to determine the role of oxidative stress associated with the disease

Studied the reaction mechanism of the penicillin-destabilizing protein beta-lactamase with the goal to design more efficient antibiotics and inhibitors of the beta-lactamase enzyme.